Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2016

Dec 13, 2016

29871_dirs_2016-12-13_01e0fcdb-4c1d-42d3-8afb-dec260c64e4a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2016-12-12

Reporting Person: Pietrowicz John W. (Sr MD Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-12-12 Common Stock Class A M 4625 $110.54 Acquired 51794 Direct
2016-12-12 Common Stock Class A S 4625 $123.3032 Disposed 47169 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-12-12 Non-Qualified Stock Option (right to buy) $110.54 M 4625 Disposed 2017-06-15 Common Stock Class A (4625) Direct

Footnotes

F1: On December 12, 2016, Mr. Pietrowicz sold an aggregate of 4,625 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $123.30 to $123.33. The Company maintains a record of the transactions and copies will be provided upon request.

F2: On June 15, 2012, these options vested with respect to 100% of the granted number of shares covered by the option.